BIOREM Inc.
BIRMF
$1.66
-$0.14-7.78%
| Weiss Ratings | BIRMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B+ | |||
| Rating Factors | BIRMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | BIRMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.46 | |||
| Price History | BIRMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.21% | |||
| 30-Day Total Return | -5.14% | |||
| 60-Day Total Return | -26.22% | |||
| 90-Day Total Return | -7.78% | |||
| Year to Date Total Return | -22.05% | |||
| 1-Year Total Return | 50.91% | |||
| 2-Year Total Return | 118.42% | |||
| 3-Year Total Return | 159.38% | |||
| 5-Year Total Return | 517.10% | |||
| 52-Week High % Change | -29.36% | |||
| 52-Week Low % Change | 55.08% | |||
| Price | BIRMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $2.35 | |||
| 52-Week Low Price | $1.07 | |||
| 52-Week Low Price (Date) | Mar 27, 2024 | |||
| 52-Week High Price (Date) | Dec 17, 2024 | |||
| Valuation | BIRMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 27.63M | |||
| Enterprise Value | 25.17M | |||
| Price/Earnings (TTM) | 7.61 | |||
| Earnings Per Share (TTM) | 0.22 | |||
| Earnings Per Share Growth | 762.45% | |||
| Price/Earnings To Growth | 0.01 | |||
| Price/Sales (TTM) | 1.05 | |||
| Price/Book (Q) | 3.56 | |||
| Enterprise Value/Revenue (TTM) | 0.85 | |||
| Price | $1.66 | |||
| Enterprise Value/EBITDA (TTM) | 4.59 | |||
| Enterprise Value/EBIT | 4.80 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BIRMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 18.64M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BIRMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 519 767 9100 | |||
| Address | 7496 Wellington Road 34 Puslinch, ON N0B 2J0 | |||
| Website | www.biorem.biz | |||
| Country | Canada | |||
| Year Founded | 1990 | |||
| Profitability | BIRMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 17.69% | |||
| Profit Margin | 12.90% | |||
| Management Effectiveness | BIRMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 21.07% | |||
| Return on Equity | 71.49% | |||
| Income Statement | BIRMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 29.61M | |||
| Total Revenue (TTM) | 29.61M | |||
| Revenue Per Share | $1.59 | |||
| Gross Profit (TTM) | 9.45M | |||
| EBITDA (TTM) | 5.49M | |||
| EBIT (TTM) | 5.24M | |||
| Net Income (TTM) | 3.82M | |||
| Net Income Avl. to Common (TTM) | 3.82M | |||
| Total Revenue Growth (Q YOY) | 165.70% | |||
| Earnings Growth (Q YOY) | 328.47% | |||
| EPS Diluted (TTM) | 0.22 | |||
| EPS Diluted Growth (Q YOY) | 286.16% | |||
| Balance Sheet | BIRMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 5.38M | |||
| Cash Per Share (Q) | $0.29 | |||
| Total Current Assets (Q) | 16.18M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 7.37M | |||
| Current Ratio (Q) | 1.914 | |||
| Book Value Per Share (Q) | $0.47 | |||
| Total Assets (Q) | 18.04M | |||
| Total Current Liabilities (Q) | 8.45M | |||
| Total Debt (Q) | 2.76M | |||
| Total Liabilities (Q) | 10.68M | |||
| Total Common Equity (Q) | 7.37M | |||
| Cash Flow | BIRMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -183.30K | |||
| Cash from Financing (TTM) | -512.80K | |||
| Net Change in Cash (TTM) | 3.62M | |||
| Levered Free Cash Flow (TTM) | 2.18M | |||
| Cash from Operations (TTM) | 4.01M | |||
